User menu

Updated Outcomes and Impact of Age With Lenalidomide and Low-Dose Dexamethasone or Melphalan, Prednisone, and Thalidomide in the Randomized, Phase III FIRST Trial.

Bibliographic reference Hulin, Cyrille ; Belch, Andrew ; Shustik, Chaim ; Petrucci, Maria Teresa ; Dührsen, Ulrich ; et. al. Updated Outcomes and Impact of Age With Lenalidomide and Low-Dose Dexamethasone or Melphalan, Prednisone, and Thalidomide in the Randomized, Phase III FIRST Trial.. In: Journal of Clinical Oncology, Vol. 34, no. 30, p. 3609-3617 (2016)
Permanent URL http://hdl.handle.net/2078.1/175042